Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: December 12th 2022 | Updated: October 18th 2024
When to Stop or Switch JAK Inhibitor Therapy in Myelofibrosis
Published: June 20th 2022 | Updated: October 18th 2024
Considering Alternatives to CAR T-Cell Therapy for Primary Refractory DLBCL
Published: August 29th 2022 | Updated: October 18th 2024
POLL: What Frontline Treatment Would You Choose for Favorable- and Intermediate-Risk RCC?
Published: December 20th 2023 | Updated: October 18th 2024
LP-184 May Expand Options for Pancreatic Cancers With DDR Defects
Published: August 31st 2021 | Updated: October 18th 2024
FDA Grants Orphan Drug Designation to LP-184 for Malignant Gliomas